How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Hycor Biomedical , Ltd. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
4 clearance records and 0 recall records in the covered releases, across 1 source company names and 3 product codes. Dated history runs from Mar 21, 2003 to Mar 7, 2005.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| MVM · Autoantibodies, Endomysial(Tissue Transglutaminase) | 2 | 0 |
| MID · System, Test, Anticardiolipin Immunological | 1 | 0 |
| MSV · System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) | 1 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| AUTOSTAT II ANTI-TISSUE TRANSGLUTAMINASE IGG ELISAK043433 · MVM | Hycor Biomedical , Ltd. | 510(k) | Mar 7, 2005FDA decision date |
| AUTOSTAT II ANTI-TISUE TRANSGLUTAMINASE IGA ELISAK033744 · MVM | Hycor Biomedical , Ltd. | 510(k) | Jan 20, 2004FDA decision date |
| AUTOSTAT II ANTI-CARDIOLIPIN IGA ELISAK030741 · MID | Hycor Biomedical , Ltd. | 510(k) | May 1, 2003FDA decision date |
| AUTOSTAT II ANTI-B-2 GLYCOPROTEIN I IGA ELISAK030397 · MSV | Hycor Biomedical , Ltd. | 510(k) | Mar 21, 2003FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.